Jaguar Health (JAGX) Minority Interest (2021 - 2026)
Jaguar Health (JAGX) posted quarterly Minority Interest of -$1.6 million for Q1 2026, down 65.34% year-over-year from -$4.5 million in Q1 2025, and down 12.51% quarter-over-quarter from -$1.4 million in Q4 2025.
Jaguar Health (JAGX) Minority Interest (2021 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Minority Interest for 6 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest fell 65.34% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$1.6 million (down 65.34% YoY), while the FY2025 annual figure was -$1.4 million, down 76.86% from the prior year.
- Minority Interest eased to -$1.6 million in Q1 2026 per JAGX's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Minority Interest topped out at $310000.0 in Q1 2023 and bottomed at -$1.6 million in Q1 2026.
- Historically, Minority Interest has averaged -$430705.9 across 5 years, with a median of -$180000.0 in 2024.
- Annual changes were most pronounced in 2023 — Minority Interest jumped 384.38% — and 2024, when it slumped 1135.94%.
- Jaguar Health's Minority Interest stood at $242000.0 in 2022, then slumped by 126.45% to -$64000.0 in 2023, then plunged by 1135.94% to -$791000.0 in 2024, then tumbled by 76.86% to -$1.4 million in 2025, then declined by 12.51% to -$1.6 million in 2026.
- Business Quant data shows JAGX's Minority Interest at -$1.6 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.57 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Mar 31, 2025 | -952,000.00 |
| Dec 31, 2024 | -791,000.00 |
| Sep 30, 2024 | -514,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Mar 31, 2024 | -180,000.00 |
| Dec 31, 2023 | -64,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 310,000.00 |
| Dec 31, 2022 | 242,000.00 |
| Sep 30, 2022 | -48,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 242,000.00 |